Table 2.
Health behavior change attributed to most insightful psychedelic experience.
| Overall | Tobacco | Alcohol | Diet | Exercise | N | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| β | p | β | p | β | p | β | p | β | p | ||
| PIQ scale | 0.42 | <0.001 | 0.00 | 0.992 | 0.13 | 0.005 | 0.18 | <0.001 | 0.17 | <0.001 | 613 |
| AMP subscale | 0.40 | <0.001 | 0.02 | 0.640 | 0.16 | 0.001 | 0.19 | <0.001 | 0.17 | <0.001 | 613 |
| GAP subscale | 0.40 | <0.001 | –0.03 | 0.490 | 0.09 | 0.055 | 0.15 | 0.001 | 0.15 | 0.001 | 613 |
AMP, Avoidance and Maladaptive Patterns; GAP, Goals and Adaptive Patterns; PIQ, Psychological Insight Questionnaire; β, standardized coefficients. Significant results (p < 0.05) highlighted in bold.
β are adjusted for age in years, gender, ethnoracial identity, sexual orientation, educational attainment, annual household income, marital status, self-reported engagement in risky behavior, lifetime use of cocaine, sedatives, pain relievers, marijuana, phencyclidine (PCP), 3,4-methylenedioxymethamphetamine (MDMA/ecstasy), inhalants, smokeless tobacco, pipe tobacco, cigars, and cigarettes daily, and age of first alcohol use.